Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial

Clinical trial NCT06221605 · COMPLETED

Trial details

NCT number: NCT06221605
Sponsor: Wecare Probiotics Co., Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2024-03-30
Primary completion: 2025-03-10
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.